Antibody-drug conjugate therapies in multiple myeloma-what's next on the horizon?
Targeted immunotherapy has arisen over the past decade to the forefront of cancer care. Notably, targeted therapies such as antibody-drug conjugates (ADCs) are becoming more recognized for a novel approach in cancer treatment. The mechanism of action of ADCs incorporates a monoclonal antibody portio...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Open Exploration Publishing Inc.,
2022-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|